Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC
Condition: Advanced Hepatocellular Carcinoma Intervention: Drug: Nivolumab Sponsors: National Cancer Center, Korea; Samsung Medical Center Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials